Your browser doesn't support javascript.
loading
Family history and gastric cancer incidence and mortality in Asia: a pooled analysis of more than half a million participants.
Huang, Dan; Song, Minkyo; Abe, Sarah Krull; Rahman, Md Shafiur; Islam, Md Rashedul; Saito, Eiko; De la Torre, Katherine; Sawada, Norie; Tamakoshi, Akiko; Shu, Xiao-Ou; Cai, Hui; Hozawa, Atsushi; Kanemura, Seiki; Kim, Jeongseon; Chen, Yu; Ito, Hidemi; Sugawara, Yumi; Park, Sue K; Shin, Myung-Hee; Hirabayashi, Mayo; Kimura, Takashi; Gao, Yu-Tang; Wen, Wanqing; Oze, Isao; Shin, Aesun; Ahn, Yoon-Ok; Ahsan, Habibul; Boffetta, Paolo; Chia, Kee Seng; Matsuo, Keitaro; Qiao, You-Lin; Rothman, Nathaniel; Zheng, Wei; Inoue, Manami; Kang, Daehee.
Affiliation
  • Huang D; Department of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.
  • Song M; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Korea.
  • Abe SK; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Baltimore, MD, USA.
  • Rahman MS; Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institute of Health, Bethesda, MD, USA.
  • Islam MR; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Saito E; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • De la Torre K; Research Center for Child Mental Development, Hamamatsu University School of Medicine, Tokyo, Japan.
  • Sawada N; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Tamakoshi A; Hitotsubashi Institute for Advanced Study, Hitotsubashi University, Tokyo, Japan.
  • Shu XO; Institute for Global Health Policy Research, National Center for Global Health and Medicine, Tokyo, Japan.
  • Cai H; Department of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.
  • Hozawa A; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.
  • Kanemura S; Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Kim J; Department of Public Health, Hokkaido University Faculty of Medicine, Sapporo, Japan.
  • Chen Y; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Ito H; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Sugawara Y; Tohoku University Graduate School of Medicine, Sendai, Miyagi Prefecture, Japan.
  • Park SK; Tohoku University Graduate School of Medicine, Sendai, Miyagi Prefecture, Japan.
  • Shin MH; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
  • Hirabayashi M; Departments of Population Health and Environmental Medicine, NYU Grossman School of Medicine, New York, NY, USA.
  • Kimura T; Division of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Gao YT; Division of Descriptive Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Wen W; Tohoku University Graduate School of Medicine, Sendai, Miyagi Prefecture, Japan.
  • Oze I; Department of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.
  • Shin A; Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ahn YO; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Ahsan H; Department of Public Health, Hokkaido University Faculty of Medicine, Sapporo, Japan.
  • Boffetta P; Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China.
  • Chia KS; Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Matsuo K; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Qiao YL; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Rothman N; Department of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.
  • Zheng W; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Korea.
  • Inoue M; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Kang D; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Gastric Cancer ; 27(4): 701-713, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38649672
ABSTRACT

BACKGROUND:

The family history of gastric cancer holds important implications for cancer surveillance and prevention, yet existing evidence predominantly comes from case-control studies. We aimed to investigate the association between family history of gastric cancer and gastric cancer risk overall and by various subtypes in Asians in a prospective study.

METHODS:

We included 12 prospective cohorts with 550,508 participants in the Asia Cohort Consortium. Cox proportional hazard regression was used to estimate study-specific adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between family history of gastric cancer and gastric cancer incidence and mortality, then pooled using random-effects meta-analyses. Stratified analyses were performed for the anatomical subsites and histological subtypes.

RESULTS:

During the mean follow-up of 15.6 years, 2258 incident gastric cancers and 5194 gastric cancer deaths occurred. The risk of incident gastric cancer was higher in individuals with a family history of gastric cancer (HR 1.44, 95% CI 1.32-1.58), similarly in males (1.44, 1.31-1.59) and females (1.45, 1.23-1.70). Family history of gastric cancer was associated with both cardia (HR 1.26, 95% CI 1.00-1.60) and non-cardia subsites (1.49, 1.35-1.65), and with intestinal- (1.48, 1.30-1.70) and diffuse-type (1.59, 1.35-1.87) gastric cancer incidence. Positive associations were also found for gastric cancer mortality (HR 1.30, 95% CI 1.19-1.41).

CONCLUSIONS:

In this largest prospective study to date on family history and gastric cancer, a familial background of gastric cancer increased the risk of gastric cancer in the Asian population. Targeted education, screening, and intervention in these high-risk groups may reduce the burden of gastric cancer.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Year: 2024 Type: Article